Tagged with M

Pharma International Co. (PIC) You took over from your father in 2006. What have been the key milestones & achievements in the company’s development since then and how does your approach differentiate from your father’s? I joined Pharma International in 2006. We had already started our production in 2000. Previously we had a British…

Eli Lilly Mexico Please can you tell us in your own words how you’ve seen the Mexican pharmaceutical market change over the past five years? Mexico is one of the top ten markets for pharmaceuticals worldwide and in the past five years it has reached a maturity level similar to that of developed…

Dar Al Dawa Development & Investment Dar al Dawa is the second biggest Jordanian pharmaceutical manufacturer. What are the main factors that allowed you to be so successful and remain in one of the top positions since the company’s inception in 1974? The key factor has been Jordan. Being poor in natural recourses, Jordan had to…

Jordan Investment Board The Jordan Investment Board (JIB) has played an important role in boosting the success story of the Jordanian economy since its inception in 1995; today, what are the JIB’s main priorities and objectives? What is currently your core agenda? The JIB attracts FDI to Jordan from all over the world.…

Hikma The company success is built on a unique and daring strategy initiated by your father. The company saw itself as a multinational company instead of a domestic company from the start, and pushed into the US. Your dad initiated the strategy, now you have the reigns to follow up on…

Boehringer Ingelheim Mexico You arrived to the position of Boehringer Ingelheim Mexico’s General Director in 2010, what are some of the most exciting milestones and achievements you have presided over during this time? I’ve been in the company for 18 years, and came back from Germany in 2010 to become the company’s first…

Pierre Fabre Farma de México Please can you give us a brief rundown of Pierre Fabre’s activities in Mexico since they opened an affiliate here, specifically the company’s milestones and achievements along the way? Pierre Fabre (PF) is now celebrating its 51st anniversary as 2012 rolls in. A French based company founded by Mr. Pierre…

Hormona Laboratorios Since we last spoke to you in 2008, Mexico has undergone a lot of regulatory changes, and we witnessed the rise of Seguro Popular, and the rise of COFEPRIS for example. What has been the biggest change in the market in the last 4 years, and how have these changes…

The Government Pharmaceutical Organization (G Dr. Witit, when we interviewed your predecessor in 2006, we talked about the vital role and leading position GPO plays in the Thai pharmaceutical industry and the company’s investments in manufacturing facilities to improve access and affordability of drugs. What have been some of the most important milestones since you…

Zuellig Pharma Thailand ‘When markets are inefficient, relationships are important. When markets are more efficient, relationships become less important because the markets become more systematic, professional, and objective in the way they operate,’ said Mr. Zwisler, former CEO of Zuellig Pharma Asia Pacific when we interviewed him in China. At which development stage…

Grunenthal Mexico Grünenthal first started operations in Mexico back in 1998, we then interviewed Mr. Klaus Kuchen in 2005, but we want to know what’s happened since. Please can you give us a brief rundown of Grünenthal’s main opportunities and challenges over the last 5 years in the Mexican market? A lot…

More Pharma Mexico There are about 250 employees and you have regional presence in Latin America. In your view as CEO, can you tell our readers about the biggest growth drivers and challenges in the Mexican pharmaceutical market since then? At More Pharma we believe we are navigating at an ever changing environment.…